News und Analysen

Many income investors probably have mixed emotions about stocks with ultra-high dividend yields. On one hand, they love the tremendous income these stocks provide. On the other hand, they might

Investing successfully in biopharmaceutical companies can sometimes require complicated calculations worthy of Albert Einstein's brain. That's because picking the right ones involves a variation of

TherapeuticsMD (NASDAQ:TXMD), a specialty pharmaceutical company focused on women’s health products, released its second quarter results on August 12, 2025, reporting a swing to profitability, with

Theravance Biopharma (NASDAQ:TBPH), a biopharmaceutical company focused on respiratory medicines and rare disease therapeutics, reported its Q2 2025 results on August 12, 2025. The company’s revenue

Viking Therapeutics (NASDAQ: VKTX) investors have seen a handsome return over the past three years, and this demonstrates that the real battle over biopharmaceutical stocks is won in the lab and

Wondering how well you'd have done if you'd invested in pharmaceutical giant Pfizer (NYSE: PFE) three years ago and hung on? Well, I'm afraid the answer isn't pretty: If you'd investing $1,000 in

Pfizer (NYSE: PFE) has been a terrible investment over the past three years. Revenue and earnings have generally moved in the wrong direction, as the company has been unable to follow up on the

Ah, 10 years ago. It was 2015, and selfie sticks and hoverboards were all over. Apple debuted its Apple Watch to much fanfare, and...perhaps you invested in shares of Zoetis (NYSE: ZTS) stock? If

In this video, I cover recent updates regarding Advanced Micro Devices (NASDAQ: AMD) and Nvidia. Watch the short video to learn more, consider subscribing, and click the special offer link below.

In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA) and Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the

BioCardia (NASDAQ:BCDA), a clinical-stage cell therapy company focused on treatments for heart disease, released its financial results for the second quarter of 2025 on August 11, 2025. The company

Agenus (NASDAQ:AGEN), a clinical-stage biotechnology company focused on developing cancer immunotherapies, reported its second quarter 2025 earnings on August 11, 2025. The company's revenue (GAAP)

It's been a tough stretch for pharmaceutical giant Pfizer (NYSE: PFE). The company enjoyed a vaccine windfall during the COVID-19 pandemic, but revenue and profits cratered as the pandemic eased and

The S&P 500 has a miserly yield of 1.2%. The average healthcare stock's yield is about 1.8%. Compared to that, Merck's (NYSE: MRK) roughly 4% yield is highly attractive. And LTC Properties' (NYSE:

If you are looking at healthcare stocks for dividend ideas in August, don't get too caught up on the sector's low 1.8% dividend yield. You can do much better than that without having to take on huge

After being a laggard to start the year, Advanced Micro Devices (NASDAQ: AMD) has rallied strongly during the summer. However, its shares took a dip following the announcement of its second-quarter

Priorities change as you enter new seasons of life. That's especially true for your retirement years. And the changing priorities can include what you want from your investments. Income usually

Biotech Nektar Therapeutics (NASDAQ: NKTR) unveiled its latest quarterly earnings after the stock market's close on Thursday, and the investor reaction was strong the following day. Happily for

Valuations have been a concern for many investors across the board, but as investors, we should constantly be putting in the work so that we are prepared for when opportunities persist.

In today's

Advanced Micro Devices (NASDAQ: AMD) reported quarterly financial results that disappointed stock market investors.

*Stock prices used were the afternoon prices of Aug. 4, 2025. The video was

In this video, I will go over Advanced Micro Devices' (NASDAQ: AMD) earnings report and explain what the market missed and why I remain extremely bullish. Watch the short video to learn more

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the special offer link below.